BridgeBio Pharma, Inc. (BBIO)

75.17 +0.66 (+0.89%) USD  |  NASDAQ  |  Dec 16, 10:26
More

BridgeBio Pharma Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Supernus Pharmaceuticals, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade